Related Experiment Video
Updated: Jul 4, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
The potential of phages to prevent MRSA infections
1Novolytics Ltd., Unit 26, Barclays Venture Centre, Sir William Lyons Road, Coventry CV4 7EZ, UK. N.H.Mann@warwick.ac.uk
Abstract:
This short review attempts to examine whether there is a potential for the use of phages capable of infecting Staphylococcus aureus to eradicate or reduce nasal colonisation, thereby reducing the overall infection burden in patient populations identified as being at risk from MRSA infections. There is clear evidence that nasal decolonisation may be of benefit to certain patient groups and also that phages can effectively combat experimentally induced S. aureus infections in animals. However, this is not in itself enough to validate the use of phages for decolonisation and, given the appearance of strains resistant to currently used topical antibiotics, there is a need for clinical trials of this prophylactic use of phages.
Insights
Bacteriophages show potential for reducing Staphylococcus aureus nasal colonization, a key step in preventing MRSA infections. Clinical trials are needed to confirm phage therapy
Area of Science:
- Microbiology
- Infectious Diseases
- Bacteriophage Therapy
Background:
- Nasal colonization by Staphylococcus aureus is a significant risk factor for various infections, particularly Methicillin-resistant Staphylococcus aureus (MRSA).
- Current decolonization strategies, including topical antibiotics, face challenges due to emerging resistance.
- Phage therapy offers a potential alternative for combating bacterial infections.
Purpose of the Study:
- To review the potential of using bacteriophages to eradicate Staphylococcus aureus nasal colonization.
- To assess the implications for reducing the infection burden in at-risk patient populations.
Main Methods:
- Literature review examining existing evidence on phage efficacy against Staphylococcus aureus.
- Analysis of studies on nasal decolonization benefits and phage activity in animal models.
Main Results:
- Phages demonstrate efficacy in combating experimentally induced Staphylococcus aureus infections in animal models.
- Evidence suggests nasal decolonization can benefit specific patient groups.
Conclusions:
- Bacteriophages hold promise for Staphylococcus aureus nasal decolonization and reducing MRSA infection risk.
- Further clinical trials are essential to validate the prophylactic use of phages, especially considering antibiotic resistance.
- Phage therapy represents a potential alternative to antibiotics for decolonization.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Bacteriophages of the Human Virome
Lytic Cycle of Bacteriophages
DNA Bacteriophages
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...

